Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Apr, 22 2026
Jan, 8 2026
Nov, 20 2025
Jul, 7 2025
Dec, 22 2025